D. E. Shaw & Co., Inc. Amicus Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 670,442 shares of FOLD stock, worth $6.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

670,442

Holding current value

$6.43 Million

% of portfolio

0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $5.55 Million - $7.03 Million	581,167 Added 650.99%	670,442 $7.16 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $323,189 - $420,074	-35,751 Reduced 28.59%	89,275 $885,000
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $1.84 Million - $2.3 Million	-161,198 Reduced 56.32%	125,026 $1.47 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $737,450 - $1.07 Million	-73,967 Reduced 20.54%	286,224 $4.06 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $9.09 Million - $10.7 Million	-771,735 Reduced 68.18%	360,191 $4.38 Million
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $5.57 Million - $6.91 Million	-519,671 Reduced 31.46%	1,131,926 $14.2 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $6.35 Million - $7.88 Million	-581,728 Reduced 26.05%	1,651,597 $18.3 Million
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $6.63 Million - $8.51 Million	-670,171 Reduced 23.08%	2,233,325 $27.3 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $640,656 - $831,810	-65,240 Reduced 2.2%	2,903,496 $30.3 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $471,623 - $841,806	-75,702 Reduced 2.49%	2,968,736 $31.9 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $2.2 Million - $3.48 Million	279,142 Added 10.09%	3,044,438 $28.8 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $5.63 Million - $7.13 Million	573,279 Added 26.15%	2,765,296 $31.9 Million
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $6.7 Million - $9.07 Million	-766,130 Reduced 25.9%	2,192,017 $20.9 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $12.7 Million - $15.6 Million	-1,456,829 Reduced 33.0%	2,958,147 $28.5 Million
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $24.5 Million - $63.6 Million	-2,664,620 Reduced 37.64%	4,414,976 $43.6 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $3.57 Million - $6.59 Million	-264,668 Reduced 3.6%	7,079,596 $163 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $3.82 Million - $4.71 Million	296,215 Added 4.2%	7,344,264 $104 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $13.1 Million - $23.3 Million	1,482,310 Added 26.63%	7,048,049 $106 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $11.5 Million - $19.4 Million	1,739,698 Added 45.47%	5,565,739 $51.4 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $7.74 Million - $11.1 Million	1,034,197 Added 37.04%	3,826,041 $37.3 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $5.17 Million - $8.54 Million	644,441 Added 30.01%	2,791,844 $22.4 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $12.6 Million - $16.5 Million	1,146,777 Added 114.61%	2,147,403 $26.8 Million
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $1.1 Million - $1.53 Million	109,646 Added 12.31%	1,000,626 $13.6 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $12.7 Million - $20.3 Million	-1,509,694 Reduced 62.89%	890,980 $8.54 Million
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $15.4 Million - $21.9 Million	-1,324,370 Reduced 35.55%	2,400,674 $29 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $9.12 Million - $11.9 Million	-694,735 Reduced 15.72%	3,725,044 $58.2 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $27 Million - $33.6 Million	1,963,566 Added 79.94%	4,419,779 $66.5 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $25.6 Million - $33.3 Million	-2,049,287 Reduced 45.48%	2,456,213 $35.3 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $52.9 Million - $71.1 Million	4,505,500	4,505,500 $67.9 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account